Allison is Associate Editorial Director for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®. She joined AJMC® in 2017. She produces and oversees written, video, and podcast content across several disease states and issues surrounding value-based care and health policy.
She has an MPA from New York University. You can connect with Allison on LinkedIn.
Pharmacists Challenged With Real-world Situations That May Affect ICI Outcomes
December 6th 2022Can a patient with metastatic cancer on immune checkpoint inhibitor (ICI) therapy use acetaminophen for pain? What about medical marijuana? And does the gut microbiome play a role? With more than a decade of real-world experience with ICIs, pharmacists learned about the potential role of these and other factors during a session at the 2022 American Society of Health-System Pharmacy Midyear Clinical Meeting & Exhibition.
VA Trying to Meet the Specific Needs of Female Veterans
December 5th 2022A clinical pharmacy specialist with the Department of Veterans Affairs (VA) described how the department is trying to address the needs of female veterans, including their reproductive health, as well as addressing disparities in chronic diseases.
Two Ways Health Systems Are Moving Toward Greater Oncology Stewardship
December 5th 2022The increasing complexity and costs of oncology care and resulting patient financial toxicity is driving more health systems to adopt oncology stewardship principles in their pharmacy practices, according to a session at the American Society of Health-System Pharmacists (ASHP) 2022 Midyear Clinical Meeting & Exposition.
Concerns About Stock Albuterol for Asthma in Illinois Schools Are Overstated, Researchers Say
November 15th 2022Liability concerns cited by education administrators and nurses regarding the use of stock albuterol in school are overblown, according to researchers who examined how legislation about the issue has played out in Illinois.
Study Finds Persistent Use of e-Cigarettes Among Middle, High School Students
November 11th 2022The report, from the CDC, said that more than 3 million youth, or almost 1 in 9, reported using tobacco this year, and that disparities persist among US middle and high school students, with the highest rates among those who struggle in school or who have severe severe psychological distress.
Nephrology Director Shares Ups, Downs of Participating in Kidney Care First
November 6th 2022It has been 3 years since new kidney care payment models were announced by HHS, and at a session at Kidney Week 2022, the associate division director of nephrology at the University of Alabama at Birmingham described his organization’s participation in Kidney Care First, one of the value-based care models announced in 2019.
Empagliflozin Cuts Risk of Cardiovascular Death, More Severe CKD by 28%, Study Finds
November 4th 2022Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, reduced the risk of death or worsening progression of chronic kidney disease (CKD) by 28%, according to results published Friday at Kidney Week 2022.
As Medical Falsehoods Persist, Concerns About Future Pandemic Readiness Grow
November 3rd 2022Physicians and scientists are worried about the future pandemic preparedness, and the reasons why are largely due to social and political influences, according to a keynote speech and panel discussion on the first day of Kidney Week 2022.
Lessons From the Pandemic to Scale Cancer Care Innovation
October 21st 2022Coverage from the New York City presentation of the Institute for Value-Based Medicine, co-chaired by Emeline Aviki, MD, MBA, of Memorial Sloan Kettering Cancer Center (MSKCC), and Robert Daly, MD, MBA, medical oncologist and lung cancer specialist at MSKCC.
Climate Change, Health Disparities Take the Stage at CHEST 2022
October 12th 2022As with many medical meetings, some of the presentations from the annual American College of Chest Physicians event will be livestreamed or on demand for later viewing, but the organizers have stressed the importance of coming together for the first time since 2019.
Medicare Part B Pricing Changes Aimed at Encouraging Biosimilar Use Begin
October 3rd 2022One of the first parts of the landmark Inflation Reduction Act took effect Monday; it boosts the add-on payment for qualifying biosimilars whose average sales price is not more than the price of its reference product from 6% of the reference product’s ASP to 8% for 5 years.
Dr Melissa O'Connor Reviews Considerations for Discharge in Home Health
September 30th 2022Melissa O'Connor, PhD, MBA, RN, FGSA, FAAN, endowed professor in Community and Home Health Nursing, M. Louise Fitzpatrick School of Nursing, Villanova University, and director, Gerontology Interest Group, discussed several factors for clinicians to consider in creating plans to discharge adults from skilled home health care.
Childhood Trauma Not a Barrier to Successful Depression Treatment, Analysis Finds
September 22nd 2022Prior research has suggested that childhood trauma is linked with a poorer response to psychotherapy and prescription drug treatment for major depressive disorder, but a large meta-analysis suggested otherwise.